NFKBIL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.14129841530553E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.85149999951417E-07 |
Normal-vs-Stage2 |
1.967830E-02 |
Normal-vs-Stage3 |
9.38430000041457E-07 |
Normal-vs-Stage4 |
5.87119999950758E-07 |
Stage1-vs-Stage2 |
6.177800E-01 |
Stage1-vs-Stage3 |
7.048500E-02 |
Stage1-vs-Stage4 |
1.984570E-03 |
Stage2-vs-Stage3 |
1.288790E-01 |
Stage2-vs-Stage4 |
3.497800E-03 |
Stage3-vs-Stage4 |
7.153800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.1298999513798E-09 |
Normal-vs-AfricanAmerican |
4.67719999996952E-06 |
Normal-vs-Asian |
9.016300E-02 |
Caucasian-vs-AfricanAmerican |
1.173360E-01 |
Caucasian-vs-Asian |
2.159400E-01 |
AfricanAmerican-vs-Asian |
3.274400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.39429978252804E-10 |
Normal-vs-Female |
1.00810000014384E-07 |
Male-vs-Female |
9.733600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.551820E-02 |
Normal-vs-Age(41-60Yrs) |
1.06419999479357E-08 |
Normal-vs-Age(61-80Yrs) |
1.13029999804226E-08 |
Normal-vs-Age(81-100Yrs) |
6.662200E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.735600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.609000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.255800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.208800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.642400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.654830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.283100E-03 |
Normal-vs-Grade 2 |
2.09099999999296E-05 |
Normal-vs-Grade 3 |
1.57830004621218E-09 |
Normal-vs-Grade 4 |
2.11289999999531E-05 |
Grade 1-vs-Grade 2 |
3.026200E-02 |
Grade 1-vs-Grade 3 |
6.099800E-01 |
Grade 1-vs-Grade 4 |
3.312000E-01 |
Grade 2-vs-Grade 3 |
2.878800E-03 |
Grade 2-vs-Grade 4 |
2.595600E-03 |
Grade 3-vs-Grade 4 |
5.936400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.439300E-03 |
Normal-vs-ccB subtype |
2.68199999986507E-07 |
ccA subtype-vs-ccB subtype |
6.613100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.44970000132739E-08 |
Normal-vs-N1 |
2.173000E-04 |
N0-vs-N1 |
3.977500E-03 |
|
|